Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (600) Arrow Down
Filter Results: (600) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,077)
    • People  (2)
    • News  (291)
    • Research  (600)
    • Multimedia  (12)
  • Faculty Publications  (248)

Show Results For

  • All HBS Web  (1,077)
    • People  (2)
    • News  (291)
    • Research  (600)
    • Multimedia  (12)
  • Faculty Publications  (248)
← Page 10 of 600 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • March 2025 (Revised March 2025)
  • Case

Good for the Seller, Good for the Buyer and Good for Society: Sampo-yoshi, Sustainability and Trust at ITOCHU

By: Sandra J. Sucher and Bethelehem Y Araya
In 2024, ITOCHU CEO Masahiro Okafuji was at a crossroads. As the thirteenth CEO since ITOCHU’s founding in 1858, he had fueled the company’s growth since 2011 by bringing ITOCHU’s founding philosophy of Sampo-yoshi (good for the seller, good for the buyer and... View Details
Keywords: Sustainability; Trust; Profit; Growth and Development Strategy; Organizational Change and Adaptation; Mission and Purpose; Corporate Social Responsibility and Impact; Environmental Sustainability; Japan
Citation
Educators
Purchase
Related
Sucher, Sandra J., and Bethelehem Y Araya. "Good for the Seller, Good for the Buyer and Good for Society: Sampo-yoshi, Sustainability and Trust at ITOCHU." Harvard Business School Case 325-053, March 2025. (Revised March 2025.)
  • August 2008 (Revised September 2008)
  • Case

The Flaxil Label (B)

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Governance; Risk and Uncertainty; Value Creation; Negotiation; Attitudes; Health Care and Treatment; Government Administration; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Barron, Greg M. "The Flaxil Label (B)." Harvard Business School Case 909-002, August 2008. (Revised September 2008.)
  • 13 Sep 2010
  • Research & Ideas

The Consumer Appeal of Underdog Branding

large corporations, such as Apple and Google, are careful to retain their underdog roots in their brand biographies." A forthcoming article coauthored by Keinan for the... View Details
Keywords: by Martha Lagace
  • 27 Sep 2013
  • Working Paper Summaries

The Impact of Conformance and Experiential Quality on Healthcare Cost and Clinical Performance

Keywords: by Claire Senot, Aravind Chandrasekaran, Peter T. Ward & Anita L. Tucker; Health
  • 19 Apr 2010
  • Research & Ideas

The History of Beauty

the consumer products giant Unilever, published some years ago. This company had a long-established business in soap and other toiletries, but spent decades after World War II striving without great success... View Details
Keywords: by Sean Silverthorne; Beauty & Cosmetics
  • 26 Feb 2007
  • Research & Ideas

The Power of the Noncompete Clause

his noncompete and avoid similar entanglements. Q: How did you frame and carry out this study, and why in Michigan? A: Other studies had looked at rates of firm foundings, but we wanted to track the mobility... View Details
Keywords: by Martha Lagace
  • August 2008 (Revised September 2008)
  • Supplement

The Flaxil Label (C): Debrief and Endnotes

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Safety; Value Creation; Negotiation; Health Care and Treatment; Sales; Pharmaceutical Industry
Citation
Purchase
Related
Barron, Greg M. "The Flaxil Label (C): Debrief and Endnotes." Harvard Business School Supplement 909-003, August 2008. (Revised September 2008.)
  • 2009
  • Book

Who Killed Health Care? America's $2 Trillion Medical Problem—and the Consumer-Driven Cure

By: Regina Herzlinger
A best seller in its category, with many printings. It has been recognized by the U.S. Chamber of Commerce as one of the books that made a difference in public policy in 2008. View Details
Keywords: Policy; Government Administration; Health Care and Treatment; United States
Citation
Find at Harvard
Purchase
Related
Herzlinger, Regina. Who Killed Health Care? America's $2 Trillion Medical Problem—and the Consumer-Driven Cure. McGraw-Hill, 2009.
  • 05 Nov 2009
  • Research & Ideas

A Market for Human Cadavers in All but Name?

that its legality and limited occurrence underline crucial new developments in markets for anatomical goods. While the international organ trade is almost unanimously condemned, human cadavers can legally... View Details
Keywords: by Michel Anteby; Health
  • Article

Are Cost Advantages from a Modern Indian Hospital Transferable to the United States?

By: R. S. Kaplan, F. Erhun, V.G. Narayanan, B. Mistry and K. Brayton, et al
We use time-driven activity-based costing to estimate the cost of personnel and space for an elective coronary artery bypass graft (CABG) surgery at two U.S. hospitals, Intermountain and Baylor Heart, and Narayana Health (NH), in India. All three hospitals use modern... View Details
Keywords: Time-Driven Activity-Based Costing; Health Care and Treatment; Cost; Organizational Structure; Performance Efficiency; India; United States
Citation
Read Now
Related
Kaplan, R. S., F. Erhun, V.G. Narayanan, B. Mistry, and K. Brayton, et al. "Are Cost Advantages from a Modern Indian Hospital Transferable to the United States?" American Heart Journal 224 (June 2020): 148–155.
  • Article

Management Practices, Relational Contracts and the Decline of General Motors

By: Susan Helper and Rebecca Henderson
General Motors was once regarded as one of the best managed and most successful firms in the world, but between 1980 and 2009 its share of the U.S. market fell from 62.6% to 19.8%, and in 2009 the firm went bankrupt. In this paper we argue that the conventional... View Details
Keywords: Organizational Design; Management Practices and Processes; Insolvency and Bankruptcy; Manufacturing Industry; Auto Industry; United States
Citation
Find at Harvard
Related
Helper, Susan, and Rebecca Henderson. "Management Practices, Relational Contracts and the Decline of General Motors." Journal of Economic Perspectives 28, no. 1 (Winter 2014): 49–72.
  • May 2024 (Revised February 2025)
  • Case

Choosing the Course of Passion: Brooke Boyarsky Pratt at knownwell

By: Jon M. Jachimowicz and Alexis Lefort
Brooke Boyarsky Pratt (HBS ’13) enjoyed considerable success in her early career, quickly climbing the ranks to associate partner at McKinsey, and later becoming an executive vice president at Berkadia, a Berkshire Hathaway portfolio company. Throughout these years,... View Details
Keywords: Passion; Career; Career Planning; Purpose; Personal Development and Career; Mission and Purpose; Identity; Business Startups; Health Care and Treatment; Health Disorders; Growth and Development Strategy; Market Entry and Exit; Health Industry; United States
Citation
Educators
Purchase
Related
Jachimowicz, Jon M., and Alexis Lefort. "Choosing the Course of Passion: Brooke Boyarsky Pratt at knownwell." Harvard Business School Case 424-040, May 2024. (Revised February 2025.)
  • 08 Oct 2010
  • What Do You Think?

Will Transparency in CEO Compensation Have Unintended Consequences?

can report from experience that differences in philosophy concerning compensation, say between Europe and the U.S., pose real issues. Not only do European CEOs and board members regard View Details
Keywords: by Jim Heskett
  • 10 Jun 2008
  • First Look

First Look: June 10, 2008

$1.6 billion. The case explores the reasons for the success of this global venture. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=808127... View Details
Keywords: Martha Lagace
  • 21 Aug 2006
  • Research & Ideas

How Europe Wrote the Rules of Global Finance

Finance, forthcoming from Harvard University Press, Abdelal discusses the rise and diminishment of capital controls in the 1900s, the coming... View Details
Keywords: by Ann Cullen
  • 03 Oct 2007
  • Research & Ideas

Dealing with the ‘Irrational’ Negotiator

to ensure that she understands why the offer is in her best interest. She may simply have misunderstood or ignored a crucial piece of information. Mistake 2: They Are Not Irrational; They Have Hidden... View Details
Keywords: by Deepak Malhotra & Max H. Bazerman
  • September 2011
  • Supplement

Expansion at Narayana Hrudayalaya

By: Tarun Khanna and Tanya Bijlani
Narayana Hrudayalaya has expanded into a multi-specialty health city in Bangalore, with a 25-acre campus that offers complex tertiary care procedures ranging from orthopedics to cancer care. In 2008, NH raised private equity from JP Morgan and Pinebridge Investments to... View Details
Keywords: Investment; Price; Health Care and Treatment; Emerging Markets; Social Enterprise; Expansion; Health Industry; Bangalore; Cayman Islands; Miami
Citation
Purchase
Related
Khanna, Tarun, and Tanya Bijlani. "Expansion at Narayana Hrudayalaya." Harvard Business School Video Supplement 712-801, September 2011.
  • August 2001 (Revised August 2012)
  • Case

BestDoctors, Inc.

By: Regina E. Herzlinger and Seth Bokser
Upon learning the news of a critical illness, patients and their families are shocked, saddened, fearful, and angry all at once. And just as soon as they catch their collective breath, they all ask the same question—a question that has the potential to infuse hope into... View Details
Keywords: Business Model; Entrepreneurship; Health Care and Treatment; Medical Specialties; Knowledge Sharing; Demand and Consumers; Health Industry
Citation
Educators
Related
Herzlinger, Regina E., and Seth Bokser. "BestDoctors, Inc." Harvard Business School Case 302-018, August 2001. (Revised August 2012.)
  • 2013
  • Working Paper

The Impact of Conformance and Experiential Quality on Healthcare Cost and Clinical Performance

By: Claire Senot, Aravind Chandrasekaran, Peter T. Ward and Anita L. Tucker
The quality of operational processes is an important driver of performance in hospitals. In particular, processes that reliably deliver both evidence-based and patient-centered care, which we call conformance and experiential quality, respectively, have been argued to... View Details
Keywords: Healthcare; Experiential Quality; Conformance Quality; Clinical Outcomes; Cost Efficiency; Quality; Service Operations; Health Care and Treatment; Performance; Outcome or Result; Health Industry
Citation
Read Now
Related
Senot, Claire, Aravind Chandrasekaran, Peter T. Ward, and Anita L. Tucker. "The Impact of Conformance and Experiential Quality on Healthcare Cost and Clinical Performance." Harvard Business School Working Paper, No. 14-024, September 2013.
  • 07 Aug 2000
  • Research & Ideas

The Business of Biotech

heralding the start of National Biotechnology Month, as January 2000 had been designated by the U.S. Senate. For biotech, in fact, View Details
Keywords: by Julia Hanna; Biotechnology; Health; Technology
  • ←
  • 10
  • 11
  • …
  • 29
  • 30
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.